Skip to main content
Home
ICYMI Multiple Sclerosis
    • FULL MENUFULL MENU Presented by
    • MDedge Neurology
    Home
    • Clinical Topics
    • Conference Coverage
    • Literature Review
    • MD-IQ
    • Clinical Edge Journal Scan

    Expert Perspectives

    April 21, 2023

    Raising Awareness for Managing Disease-Modifying Therapies in Aging Persons With Multiple Sclerosis

    April 21, 2023
    Bianca Weinstock-Guttman, MD
    Bianca Weinstock-Guttman, MD
    April 21, 2023
    ICYMI Multiple Sclerosis
    February 10, 2023

    Anti-CD20 Monoclonal Antibodies for Treating Multiple Sclerosis

    February 10, 2023
    Vijayshree Yadav, MD, MCR, FANA, FAAN
    Vijayshree Yadav, MD, MCR, FANA, FAAN
    February 10, 2023
    ICYMI Multiple Sclerosis
    January 25, 2023

    Despite ongoing challenges, experts are optimistic about the future of MS therapy

    January 25, 2023
    Frieda Wiley
    Frieda Wiley
    January 25, 2023
    ICYMI Multiple Sclerosis
    December 15, 2022

    MS and Emotional Stress: Is There a Relation?

    December 15, 2022
    Ahmed Z. Obeidat, MD, PhD
    Ahmed Z. Obeidat, MD, PhD
    December 15, 2022
    ICYMI Multiple Sclerosis
    Read More

    Clinical Edge Journal Scan

    May 27, 2022

    Commentary: COVID-19 Treatment and Disease-Modifying Therapies in MS, June 2022

    May 27, 2022
    Mark Gudesblatt, MD
    Mark Gudesblatt, MD
    May 27, 2022
    ICYMI Multiple Sclerosis
    May 18, 2022

    Multiple sclerosis type and female sex predict worsening lower urinary tract symptoms

    May 18, 2022
    May 18, 2022
    ICYMI Multiple Sclerosis
    May 18, 2022

    Multiple sclerosis: Reduced humoral response contributes to breakthrough SARS-CoV-2 infection in patients on DMTs

    May 18, 2022
    May 18, 2022
    ICYMI Multiple Sclerosis
    May 18, 2022

    T-cell response after third SARS-CoV-2 vaccination in patients with MS on ocrelizumab

    May 18, 2022
    May 18, 2022
    ICYMI Multiple Sclerosis
    Read More

    MD-IQ

    Fatigue in Multiple Sclerosis

    Multiple Sclerosis and Visual Dysfunction

    Multiple Sclerosis Subtypes

    Multiple Sclerosis Risk Factors

    More

    Clinical Topics

    January 25, 2023

    Despite ongoing challenges, experts are optimistic about the future of MS therapy

    January 25, 2023
    Frieda Wiley
    Frieda Wiley
    January 25, 2023
    ICYMI Multiple Sclerosis
    August 30, 2022

    Ublituximab bests teriflunomide in head-to-head clinical trials

    August 30, 2022
    Kate Johnson
    Kate Johnson
    August 30, 2022
    ICYMI Multiple Sclerosis
    June 22, 2022

    COVID vaccination in DMT-treated MS patients: New data

    June 22, 2022
    Nancy A. Melville
    Nancy A. Melville
    June 22, 2022
    CMSC: Consortium of Multiple Sclerosis Centers
    ICYMI Multiple Sclerosis
    June 3, 2022

    B-cell level may affect COVID booster efficacy in MS

    June 3, 2022
    Kelli Whitlock Burton
    Kelli Whitlock Burton
    June 3, 2022
    ICYMI Multiple Sclerosis
    Read More

    Literature Review

    June 2, 2023

    Stem cell transplants are more effective than some MS therapies

    June 2, 2023
    Jim Kling
    Jim Kling
    June 2, 2023
    ICYMI Multiple Sclerosis
    February 1, 2023

    Biosimilar equal to natalizumab for relapsing remitting MS

    February 1, 2023
    Pauline Anderson
    Pauline Anderson
    February 1, 2023
    ICYMI Multiple Sclerosis
    January 3, 2023

    Stem cell transplant superior to DMTs for secondary progressive MS

    January 3, 2023
    Kelli Whitlock Burton
    Kelli Whitlock Burton
    January 3, 2023
    ICYMI Multiple Sclerosis
    December 21, 2022

    Four-gene signature linked to increased PML risk

    December 21, 2022
    Neil Osterweil
    Neil Osterweil
    December 21, 2022
    ICYMI Multiple Sclerosis
    December 5, 2022

    High drug costs exclude most neurology patients from cutting-edge treatment

    December 5, 2022
    Megan Brooks
    Megan Brooks
    December 5, 2022
    ICYMI Multiple Sclerosis
    Read More

    Conference Coverage

    June 15, 2023

    Multiple sclerosis has a misdiagnosis problem

    June 15, 2023
    Nancy A. Melville
    Nancy A. Melville
    June 15, 2023
    CMSC: Consortium of Multiple Sclerosis Centers
    ICYMI Multiple Sclerosis
    June 13, 2023

    No apparent drug interaction with ozanimod and antidepressants

    June 13, 2023
    Tara Haelle
    Tara Haelle
    June 13, 2023
    CMSC: Consortium of Multiple Sclerosis Centers
    ICYMI Multiple Sclerosis
    June 9, 2023

    ‘Strikingly positive’ effect of novel MS agent

    June 9, 2023
    Nancy A. Melville
    Nancy A. Melville
    June 9, 2023
    CMSC: Consortium of Multiple Sclerosis Centers
    ICYMI Multiple Sclerosis
    June 9, 2023

    MS relapse rates similar between anti-CD20 mAbs and switching to fumarates

    June 9, 2023
    Tara Haelle
    Tara Haelle
    June 9, 2023
    CMSC: Consortium of Multiple Sclerosis Centers
    ICYMI Multiple Sclerosis
    June 9, 2023

    Shingles infection rates higher in patients with MS

    June 9, 2023
    Tara Haelle
    Tara Haelle
    June 9, 2023
    CMSC: Consortium of Multiple Sclerosis Centers
    ICYMI Multiple Sclerosis
    June 8, 2023

    Ozanimod for relapsing MS shows long-term safety, efficacy with age differences

    June 8, 2023
    Tara Haelle
    Tara Haelle
    June 8, 2023
    CMSC: Consortium of Multiple Sclerosis Centers
    ICYMI Multiple Sclerosis
    June 6, 2023

    Multiple changes in NMOSD treatment for nonmedical reasons tied to poorer outcomes

    June 6, 2023
    Nancy A. Melville
    Nancy A. Melville
    June 6, 2023
    CMSC: Consortium of Multiple Sclerosis Centers
    ICYMI Multiple Sclerosis
    June 6, 2023

    Racial, ethnic disparities persist in access to MS care

    June 6, 2023
    Tara Haelle
    Tara Haelle
    June 6, 2023
    CMSC: Consortium of Multiple Sclerosis Centers
    ICYMI Multiple Sclerosis
    Read More

    This Publication

    • MDedge Neurology
    • Clinical Neurology News
    • MD-IQ

    Top Sections

    • Clinical Topics & News
    • Conference Coverage
    • Literature Monitor
    • Literature Review

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    FULL MENU FULL MENU Presented by
    • FULL MENU FULL MENU
      • Clinical Topics
      • Conference Coverage
      • Expert Perspectives
      • Literature Review
      • MD-IQ
      • Clinical Edge Journal Scan

      More

      • MDedge Neurology
    • Clinical Topics
    • Conference Coverage
    • Expert Perspectives
    • Literature Review
    • MD-IQ
    • Clinical Edge Journal Scan

    More

    • MDedge Neurology